Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS
PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS


Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2019 and provided 2020 financial guidance.



Results for the fourth quarter and the full year of 2019 and 2018(7)

Agilent Introduces New Cutting-Edge SureSelect DNA Kit
Agilent Introduces New Cutting-Edge SureSelect DNA Kit


Agilent Technologies Inc. (NYSE: A) today introduced a new product designed to address key challenges that laboratories encounter when preparing DNA sequencing libraries for their research. The new

Humana Foundation Investing $7.6 Million in Eight Communities to Address Social Determinants of Health
Humana Foundation Investing $7.6 Million in Eight Communities to Address Social Determinants of Health


The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 38 years, is investing $7.6 million in eight communities across the southeastern United States to address social

Pfizer Vaccines Launches Global Centers of Excellence Network to Conduct Real-World Research on Vaccine-Preventable Diseases Affecting Adults
Pfizer Vaccines Launches Global Centers of Excellence Network to Conduct Real-World Research on Vaccine-Preventable Diseases Affecting Adults


Pfizer Inc. (NYSE: PFE) announced today the launch of its Vaccines Division’s Centers of Excellence Network, a global program of collaborations with academic institutions to conduct real-world

Agilent Announces CrossLab Group Leadership Transition
Agilent Announces CrossLab Group Leadership Transition


Agilent Technologies Inc. (NYSE: A) today announced that Mark Doak, Agilent senior vice president and president of the Agilent CrossLab Group, has decided to retire on May 1, 2020. The company has

Eine neu veröffentlichte multizentrische RCT zeigt, dass Smith+Nephew PICO◊ sNPWT kanisterlose Unterdruck-Wundtherapie herkömmlicher tNPWT bei der Reduzierung von Wundfläche, -tiefe und -volumen bei DFU und UCV überlegen ist
Eine neu veröffentlichte multizentrische RCT zeigt, dass Smith+Nephew PICO◊ sNPWT kanisterlose Unterdruck-Wundtherapie herkömmlicher tNPWT bei der Reduzierung von Wundfläche, -tiefe und -volumen bei DFU und UCV überlegen ist


Smith+Nephew (LSE:SN, NYSE:SNN), das globale Medizintechnikunternehmen, freut sich, die Veröffentlichung von Ergebnissen aus einer neuen randomisierten kontrollierten klinischen Studie (RCT)

Pfizer’s Greenstone and Digital Men’s Health Clinic Roman Collaborate to Offer Patients Remote Access to the Only FDA-Approved Authorized Generic Version of Viagra® (sildenafil citrate)
Pfizer’s Greenstone and Digital Men’s Health Clinic Roman Collaborate to Offer Patients Remote Access to the Only FDA-Approved Authorized Generic Version of Viagra® (sildenafil citrate)


Greenstone, Upjohn’s U.S.-based generics business and a wholly owned subsidiary of Pfizer Inc., and Roman, an innovative digital healthcare clinic for men, today announced a supply agreement to

Texas Senior Games Opens Registration for 2020 Games, Announces Humana as Top Sponsor
Texas Senior Games Opens Registration for 2020 Games, Announces Humana as Top Sponsor


Registration for the 2020 Texas Senior Games, the multi-sport competition for seniors that will be held March 26 through April 5, 2020, in San Antonio, is now open. For the first time, leading

Agilent Wins Multiple Innovation Awards
Agilent Wins Multiple Innovation Awards


Agilent Technologies Inc. (NYSE: A) today announced that both The Analytical Scientist and The Medicine Maker have honored the Agilent InfinityLab LC/MSD iQ system with 2019 Innovation Awards.

Family Physicians Group Names Cheri Greenfield La-Tour Market President
Family Physicians Group Names Cheri Greenfield La-Tour Market President


Family Physicians Group, one of the Central Florida’s largest at-risk providers serving Medicare Advantage and Managed Medicaid HMO patients in Greater Orlando, has named Cheri Greenfield La-Tour

Dexcom Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 13, 2020 at 4:30 p.m. Eastern Time
Dexcom Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 13, 2020 at 4:30 p.m. Eastern Time


DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2019 financial results after market close on Thursday, February 13, 2020. Management will hold a

Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema


Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic

Clinical trial demonstrated superior wound closure rates with PICO◊ compared to traditional NPWT in lower extremity ulcers1
Clinical trial demonstrated superior wound closure rates with PICO◊ compared to traditional NPWT in lower extremity ulcers1


Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the publication of a new randomized controlled trial (RCT) which demonstrated that the use of PICO Single

7 of the Top 20 Pharma Companies Adopt Veeva Vault Study Startup
7 of the Top 20 Pharma Companies Adopt Veeva Vault Study Startup


Accelerating study start-up is a top priority among leading life sciences companies. With this shift underway, an increasing number of organizations are selecting Vault Study Startup from Veeva

Ipsen Appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief Medical Officer
Ipsen Appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief Medical Officer


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200113005846/en/



(Photo: Business Wire)




Ipsen (Euronext: IPN; ADR

Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020
Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020


Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2019 following the close of market on Wednesday, January 29, 2020.



On the same day, at

Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics
Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics


Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership

Illumina and Roche Partner to Broaden Patient Access to Genomic Testing
Illumina and Roche Partner to Broaden Patient Access to Genomic Testing


Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year

Waters to Acquire Andrew Alliance
Waters to Acquire Andrew Alliance


Waters Corporation (NYSE:WAT) announced today that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including

Dexcom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2019 and Provides Initial 2020 Outlook
Dexcom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2019 and Provides Initial 2020 Outlook


DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2019 to be

Illumina reicht Patentverletzungsklage gegen BGI in Schweden und dem Vereinigten Königreich ein
Illumina reicht Patentverletzungsklage gegen BGI in Schweden und dem Vereinigten Königreich ein


Illumina, Inc. (NASDAQ: ILMN) gab heute bekannt, dass das Unternehmen zwei weitere Patentverletzungsklagen im Zusammenhang mit den Sequenzierprodukten von BGI, einschließlich des DNBSeq-400 (auch

Veeva to Present at the 38th Annual J.P. Morgan Healthcare Conference
Veeva to Present at the 38th Annual J.P. Morgan Healthcare Conference


Veeva Systems (NYSE:VEEV) today announced that Paul Shawah, SVP of Veeva Commercial Cloud, will present at the 38th annual J.P. Morgan Healthcare Conference on Thursday, Jan 16, 2020, at 10:00 a.m

Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom


Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI’s sequencing products, including the DNBSeq-400 (also known as MGISeq-2000)

Quidel Announces Preliminary Revenue for Fourth Quarter 2019
Quidel Announces Preliminary Revenue for Fourth Quarter 2019


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects

Application Process for 2020 Louisville-Based Community Partners Program Opens
Application Process for 2020 Louisville-Based Community Partners Program Opens


The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 38 years, today announced the details of its 2020 Community Partners Program. Through this initiative, The Humana